Rabbit anti-p21/CIP1/CDKN1A Recombinant Monoclonal Antibody [BLR337M]
Catalog #
p21/CIP1/CDKN1A
Human
ICC
,IHC
,IP
,WB
Rabbit
Recombinant Monoclonal
BLR337M
Whole IgG
between 100 and 150
IgG
Purified
Product Details
Human
Human
2 - 8 °C
1 year from date of receipt
Phosphate Buffered Saline (PBS) with 0.1% BSA and 0.09% Sodium Azide
Request Formulation Change
Phosphate Buffered Saline (PBS) with 0.09% Sodium Azide, BSA-Free
Request Formulation Change
Recombinant antibody was purified from cell culture supernatant.
Immunogen was a peptide representing a region between residue 100 and 150 of human cyclin-dependent kinase inhibitor 1 (aka p21 or CIP1) using the numbering given in entry NP_000380.1 (Gene ID 1026).
p21/CIP1/CDKN1A is a potent cyclin-dependent kinase inhibitor. It binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. Expression of p21/CIP1/CDKN1A is tightly controlled by the tumor suppressor protein p53, and it mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. p21/CIP1/CDKN1A can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. [taken from NCBI Entrez Gene (Gene ID: 1026)].
Alternate Names
CAP20;CDK-interacting protein 1;CDK-interaction protein 1;CDKN1;CIP1;cyclin-dependent kinase inhibitor 1;cyclin-dependent kinase inhibitor 1A (p21, Cip1);DNA synthesis inhibitor;MDA-6;melanoma differentiation associated protein 6;Melanoma differentiation-associated protein 6;P21;p21CIP1;SDI1;WAF1;wild-type p53-activated fragment 1
Applications